Form 4 for TMO Thermo Fisher Scientific
Accepted 2025-11-14 00:00:00 ET · period of report 2025-11-13 · accession 0000097745-25-000166 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-14 | 2025-11-13 | TMO | Lagarde Michel | EVP, COO | M - OptEx | $253.99 | +4,638 | 28.1K | +20% | +$1.18M |
| D | 2025-11-14 | 2025-11-13 | TMO | Lagarde Michel | EVP, COO | S - Sale+OE | $594.42 | -4,638 | 23.5K | -16% | -$2.76M |
| D | 2025-11-14 | 2025-11-13 | TMO | Lagarde Michel | EVP, COO | M - OptEx | $0.00 | -4,638 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-13 | M | A | 4,638 | $253.99 | 28,117.91 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-13 | S | D | 4,638 | $594.42 | 23,479.91 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $594.36 to $594.88, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-11-13 | M | D | 4,638 | $0.00 | 0 | D | $253.99 · — to 2026-02-26 | 4,638 Common Stock | (F2) The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023. |